Invention Application
- Patent Title: CXCL8 INHIBITOR AND PHARMACEUTICAL COMPOSITION THEREOF FOR USE IN THE TREATMENT OF CANCER-RELATED FATIGUE
-
Application No.: US17800634Application Date: 2021-02-19
-
Publication No.: US20230090111A1Publication Date: 2023-03-23
- Inventor: Marcello ALLEGRETTI , Pieradelchi RUFFINI
- Applicant: Dompe' farmaceutici SpA
- Applicant Address: IT Milano
- Assignee: Dompe' farmaceutici SpA
- Current Assignee: Dompe' farmaceutici SpA
- Current Assignee Address: IT Milano
- Priority: EP20158787.0 20200221
- International Application: PCT/EP2021/054231 WO 20210219
- Main IPC: A61K31/18
- IPC: A61K31/18 ; A61P43/00 ; A61K31/426 ; A61K9/00 ; A61P35/00
Abstract:
The present invention relates to a CXCL8 inhibitor and a pharmaceutical composition thereof, for use in the prevention or treatment of cancer-related fatigue in a cancer patient.
Information query
